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Abstract:
Background: Leprosy also known as Hansen’s dis-
ease (HD), is a chronic infection caused by the Myco-
bacterium leprae. Mast cells in leprosy have been in-
vestigated in the recent past and are being examined
as a basis for future studies. Materials and Methods:
119 leprosy cases and 14 control biopsies stained with
toluidine blue were assessed for density and distribu-
tion of mast cells. 38 cases had undergone treatment.
Results: Significantly higher mast cell count was ob-
tained in the skin lesions of borderline lepromatous lep-
rosy. On comparison with controls lower counts were
observed in polar tuberculoid and indeterminate lep-
rosy whereas higher values were observed in all other
groups. The mast cell count in leprosy is probably de-
termined by the pattern of cytokines released by the T
lymphocytes. Mast cell density assessed after treat-
ment was reduced in borderline tuberculoid and bor-
derline lepromatous cases however in indeterminate
group, the counts were increased. Conclusion: The
distribution of mast cells in leprosy is a variable feature
and there is no constant site or predilection for a par-
ticular type of leprosy.
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Introduction:
Mast cells can no longer be regarded simply as cells
that initiate acute allergic reaction [1]. Paul Ehrlich
who coined the term “Mastzellen” also proposed that
mast cells help in maintaining nutrition of connective
tissue [2]. They can orchestrate the infiltration of
leucocytes into sites of mast cell activation, an effect
that develops over a period of several hours and is at
least partially cytokine dependent [1].
Mast cells have received little attention in leprosy but
evidence linking them with delayed type hypersensi-
tivity reaction raises the possibility that they may be
of some importance in leprosy in both nonreactional
and reactional states [3]. In murine leprosy, in early
stages mastocytosis was observed and there was dis-
integration, disruption and degranulation of mast cell
number and release of histamine, heparin and 5-Ht,
thus permitting an afflux of immune factors into af-
fected areas [4].
Naik et al 2003 [5] suggested that periodic follow up
of indeterminate and borderline lesions for mast cell
count might help in predicting stability of lesions. Ac-
cording to Bagwan et al 2004 [6], the study of mast
cells provides a very cost effective way of having in-
sight into immunological aspects of leprosy and tu-
berculosis and has a diagnostic application. Montagna
NA et al 2005 [7] have related increase in tryptase
rich mast cells to epineuria collagenization in leprosy
through their tryptase secretion.
The present study was conducted to ascertain the
density and distribution of mast cells in leprosy and to
correlate the differences in mast cell density in lesions
relapsing after therapy.
Materials and Methods:
The present study was conducted in Department of
Pathology, Mahatma Gandhi Institute of Medical Sci-
ences Wardha, Maharashtra on 119 histopathologi-
cally confirmed cases of leprosy irrespective of their
ages, sex and histological type and 14 biopsies from
normal skin as controls. In each case punch biopsy of
6mm was taken from the margin of the lesion with
subcutaneous tissue and fixed in 10% buffered for-
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malin. Tissue was processed and serial sections were
stained with hematoxylin and eosin for
histomorphological study of skin, Fite Feroco for acid
fast bacillus and toluidine blue stain for mast cells.
Leprosy cases were classified into five groups ac-
cording to Ridley and Jopling [8] classification as
Lepromatous leprosy (LL), borderline lepromatous
leprosy (BL), mid borderline leprosy (BB), Border-
line tuberculoid leprosy (BT) and Tuberculoid lep-
rosy (TT). Cases where there were one or two small
hypopigmented macules on the skin with a slight sen-
sory impairment clinically and where the skin biopsy
histologically showed a nonspecific lymphocyte infil-
trate around dermal nerve twigs with occasional acid
fast bacillus were labeled as indeterminate leprosy. In
each case the mast cell density was calculated in tolui-
dine blue stained sections using Olympus CH30
model biological microscope in all the cases using
EA100 oil immersion objective and NCWHK 10x
eyepiece. With these specifications and the magnifi-
cation of 1000X and field of view diameter of 0.18
mm., the radius r of a circle was calculated as = 3.14
x 0.09 x 0.09 sq.mm = 0.0254 sq.mm
 Thus, for counting in 1 sq.mm area we added the
cell count in 1/0.0254 =39.37 fields or rounded upto
40 fields. Therefore, 40 non overlapping fields were
counted to obtain mast cell count per sq.mm. area
and their distribution was further studied
subepidermally, in granuloma, intervening dermis, skin
appendages, blood vessels and nerves.
Results:
Out of the 119 leprosy cases in the present study
there were 8TT, 42BT, 19BL, 9LL, 34. Indetermi-
nate and 7 Erythema nodosum leprosum cases. Maxi-
mum number of patients were in the age groups of
21-30 years. Male to female ratio was 2:1. The mean
density of mast cells in the 14 control biopsies was
29.28 sq.mm. The density of mast cells in the skin
lesions in 119 cases is given in (Table 1).
On comparison with controls, it was observed that
lower counts were observed in polar tuberculoid and
indeterminate leprosy, whereas higher values were
observed in all other groups. The highest values were
seen in borderline lepromatous lesions (Mean of 35
cells per sq.mm). However, on statistical analysis the
differences between mean mast cell counts in cases
and control were not found to be significant (p>0.05).
The total mean mast cell count was analysed in dif-
ferent age groups in the skin biopsies of controls and
was maximum in the age group 41-50 years that is
60 cells/sq.mm and females showed slightly higher
mast cell density when compared to males.
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Table 1: Density of Mast Cells in the Skin Lesions of Various Types of Leprosy
Sr.
No.
Mean mast cell density per sq.mm
Std. Deviation
Type of leprosy
Mean
Tuberculoid leprosy
Borderline Tuberculoid leprosy
Borderline Lepromatous leprosy
Lepromatous leprosy
Indeterminate leprosy
Erythema nodosum leprosum
Control
1
2
3
4
5
6
7
21.25
30.35
35.00
31.66
27.94
30.00
29.28
05.17
15.43
14.71
17.85
13.93
15.54
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The distribution of mast cells was more commonly
found in granulomas in skin biopsies of Erythema
nodosum leprosum (40% cases), Lepromatous lep-
rosy (35.71% cases) and in Borderline lepromatous
leprosy (33.33% cases) whereas in Indeterminate
leprosy mast cells were predominantly located around
the skin appendages, in tuberculoid group they were
preferentially located in the intervening dermis. The
mast cells were more commonly observed in subepi-
dermal location in the control group.
Active mast cell morphology was commonly seen in
controls as well as in patients of tuberculoid leprosy,
borderline tuberculoid leprosy and borderline lepro-
matous leprosy. However, the fusiform morphology
was commonly observed in lepromatous leprosy, in-
determinate leprosy and erythema nodosum leprosum.
Active degranulation was observed in only three cases.
Table 2: Comparison of Mast Cell Density in the Patients Before and After Leprosy Treatment.
Sr.
No.
Mean mast cell density per sq.mm
After Treatment
Type of leprosy
Before Treatment
Borderline Tuberculoid leprosy
Borderline Lepromatous leprosy
Indeterminate leprosy
1
2
3
32.59(18.20)
37.50(14.63)
26.36(13.10)
26.33(07.43)
33.18(15.21)
30.80(15.49)
Mast cell density was correlated with previous skin
biopsies on treatment and in 38 patients who relapsed
after treatment and in patients who developed new
active lesions.
It was observed that the mean mast cell density per
sq. mm was decreased in both borderline tuberculoid
leprosy and borderline lepromatous groups; however
in indeterminate groups the counts increased after
treatment. However on statistical analysis the differ-
ences were not found to be significant. Morphologi-
cal examination of mast cells in these cases revealed
that fusiform mast cells were more commonly seen in
all three groups after relapse as compared to pre-
dominant active morphology in same groups before
treatment.
Discussion:
Arvy (1956) [9] has demonstrated an increase of mast
Microphotograph 1: Shows Presence of Mast
Cells in Midst of Foamy Macrophages in Lep-
romatous Leprosy. (Toludine blue stain)
Microphotograph 2: Shows Presence of Mast
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Microphotograph 3: Showing Active Degranu-
lation of Mast Cell in Intervening Dermis.
(Toludine blue stain)
Microphotograph 4: Showing Active Morphol-
ogy of Mast Cell in Indeterminate Leprosy.
(Toludine blue stain)
cell in most organs of mouse following estrogen ad-
ministration. Other authors have also observed that
mast cells are present in significantly higher numbers
in females than males. However with advancing age
these values decreased to the same level in both the
sexes. A higher mast cell density was observed in the
present study in the control females and this could be
probably attributed to the effect of female sex hor-
mones. The mean mast cell density has been highest
in borderline lepromatous leprosy (35 cells/sq.mm).
Lower values than control have been observed in
polar tuberculoid and indeterminate leprosy where as
all other groups have shown higher values than con-
trols in the present study. KR Chatura et al 2012 [10]
also have had similar results. The mean mast cell count
per2 mm at the tuberculoid pole has been lowest in
TT 7.9 and highest in BT 14.23. At the lepromatous
end, it has been highest in BL 9.21, while in LL it has
been 8.23.  Highest counts have been seen in the
borderline types overall.  In their study also the cor-
relation coefficient between histopathological diagnosis
and mast cell count has been found to be -0.17, which
is a negative correlation but not to a significant de-
gree. Magalhaes Gde O et al 2007 [11] in a quantita-
tive and morphometric study of tryptase positive mast
cells using antitryptase antibody in order to quantify
mast cells in leprosy lesions have also observed that
lepromatous leprosy group has had the lowest der-
mal mast cell density values among the three groups.
Furthermore, the average mast cell cross-sectional
area has been significantly higher in lepromatous lep-
rosy in comparison to the borderline borderline lep-
rosy and tuberculoid leprosy biopsies suggesting mast
cell functional differences within the groups. The higher
mast cell density in the tuberculoid and borderline
groups is considered as an indirect evidence of role
of mast cells in the activated immune response to
Mycobacterium leprae infection. Rav et al 1990 [12]
have also observed that there is a tendancy for de-
creasing mast cell count from the lepromatous to the
tuberculoid end of the spectrum. Aroni et al 1993
[13] have found that tuberculoid group has shown
lower mast cell count than lepromatous lesions.
Mysorekar et al 2001 [14] have observed that very
high mast cell density is seen in lepromatous patients
as compared to tuberculoid Hansen disease. The in-
determinate group also has shown very high mast cell
density. Bagwan et al 2004 [6] have observed nor-
mal mast cell counts in indeterminate and tuberculoid
leprosy and have shown a rise in counts according to     Journal of Krishna Institute of Medical Sciences University
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immunological spectrum from borderline tuberculoid
to lepromatous leprosy. We have also observed that
cells count tend to be higher in lepromatous Hansen’s
disease as compared to tuberculoid Hansen’s dis-
ease as described by other authors. Only Naik et al
2003 [5] have observed high mast cell count in tu-
berculoid cases and lowest in indeterminate leprosy.
Increase in density of mast cell has also corresponded
with normal increase in density observed in various
histological types of leprosy and depends on the physi-
ological changes in the mast cell count which are ob-
served in control groups of the present study.
The raised mast cell count in lepromatous Hansen
disease over that of tuberculoid leprosy can be ex-
plained on the predominance of T-helper cell type 2
(TH-2) response of anti-inflammatory cytokine lib-
eration in lepromatous leprosy as against T helper
cell type 1 (TH-1) response of proinflammatory
cytokine liberation in tuberculoid leprosy.  Mast cells
are believed to be associated with a variety of
cytokines such as TNF-alpha, IL-1, IL-4, IL-5, IL-
6 and GM-CSF most of which belong to the TH-2
response. Predominance of TH-2 response in lepro-
matous leprosy thus explains the presence of raised
mast cell count in it [14]. IL-6, an interleukin that
induces acute phase proteins, is identified here as an-
other molecule that enhances adhesion of mast cells
to ECM molecules by an up regulation of integrin
mRNA and protein expression of these cells. Speci-
ficity of this effect is underlined by blockage of HMC-
1 binding to fibronectin, less so to vitronectin, by an-
tibodies against α 1, α 5 and α4α5 integrins, and by
demonstration of the IL-6 receptor on HMC-1 cells.
In another study, the platelet-derived growth factors,
TNF-α, IFN-γ, IL-1, IL-4, and endothelial growth
factors α and β have failed to induce murine mast
cell ECM adhesion. In contrast, IL-1 has been re-
ported to cause a 5-fold increase of adherence of
uterine human mast cells to endothelial cells. [15]
We  have also observed higher mast cell counts in
borderline lepromatous leprosy than in polar lepro-
matous leprosy. This may also indicate that the (TH-
2) response is higher in borderline lepromatous lep-
rosy than in polar lepromatous disease. The mast cell
density is known to differ between different anatomi-
cal locations in the normal skin. Aroni et al 1993 [13]
have not found any difference between distribution of
mast cells in tissues of tuberculoid and lepromatous
leprosy. Mysorekar et al 2001 [14] and Naik et al
2003 [5] also have not found any difference in distri-
bution of mast cell in different lesions of leprosy. Cree
et al 1990 [15] have observed that the density of mast
cells has been greatest in granuloma and least in inter-
vening dermis in both paucibacillary and multibacillary
type. In the granulomas mast cell density is observed
to be reduced in multibacillary as compared with
paucibacillary patients whereas Mahasavariya et al
2000 [3]  have observed that the greatest number of
mast cells have been in interstitium and not in granu-
loma. The findings of the present study suggest that
the distribution of mast cells in leprosy lesions is a
variable feature and there is no constant site or predi-
lection for a particular type of leprosy.
Cree et al 1990 [16] have suggested that density within
granulomata is determined by systemic response to
infection by M. leprae and not by local factors. How-
ever we have observed mast cell density to be high in
granulomas in patients of erythema nodosum
leprosum. In the absence of sequential studies of bi-
opsies during and after the development of reactional
stage the clinical importance of these differences is
not clear. But the fact that such a difference exists in
mast cell density might be related to a tendancy to
develop reactions and it can be hypothesized that these
patients with higher mast cell density in granulomas
might be susceptible to more damaging reversal re-
actions due to the release of mediators from the mast
cells seems to be an attractive hypothesis and is worth
further study. Cree et al 1990 [16] have also observed
that the appearance of mast cells in leprosy lesions is
very variable. They have observed several morpho-
logically distinct variants-the active mast cells, fusi-     Journal of Krishna Institute of Medical Sciences University
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form mast cells or resting mast cells. They have also
observed that the fusiform mast cells are present more
commonly in the inflammatory foci. Most of the au-
thors agree with Cree et al 1990 [16] that in histol-
ogy there are too many mast cells of indeterminate
morphology that do not allow the typing of mast cells
easily and they cannot be counted separately on mor-
phological grounds alone and therefore on routine his-
tological examinations it is not possible to differenti-
ate or assign any morphological subtype designation
for all mast cells.
Mast cell density has also been correlated with pre-
vious skin biopsies in 38 patients who relapsed after
treatment or who developed new active lesions. Mast
cell density is reduced in borderline tuberculoid and
borderline lepromatous leprosy lesions after treatment
but in indeterminate group the counts show increase.
Active morphology of mast cells has been observed
before treatment and fusiform morphology after treat-
ment. Van Hale et al 1984 [17] have observed the
presence of mast cells to be much more common be-
fore treatment than in those undergoing therapy. The
change in mast cell density after treatment is possible
because most of the lesions upgrade to become more
of tuberculoid type with changes in the cytokine pat-
tern. Antunes et al 2003 [18] have observed a rela-
tive increase of MC tryptase in the inflammatory infil-
trate in reactional biopsies. Also, the total number of
mast cells and the MC tryptase/MC tryptase, chymase
ratio in inflammatory infiltrate has been significantly
higher than in intervening dermis. Moubasher et al
1998 [19] have observed significant reduction in se-
rum cytokines after one year of treatment in
paucibacillary forms than in multibacillary patients. They
have observed significant reduction in serum cytokines
after one year of treatment in paucibacillary forms than
in multibacillary forms even touching the levels seen in
healthy controls. This suggests that mast cell morphol-
ogy may show significant alteration as a response to
therapy or in response to cytokine pattern leading to
the development of new active lesions.
However, before labeling this cell as a master cell of
immune response we need to carry out studies which
take into account the normal biological variations in
the number and morphology of the mast cells.     Journal of Krishna Institute of Medical Sciences University
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